VLDLR-AS1 and hepatocellular carcinoma: Takahashi and colleagues [67] have proposed the potential role of linc-VLDLR as a novel signaling mediator that can contribute to chemotherapeutic stress responses in hepatocellular cancer (HCC) through extracellular vesicle-mediated intercellular signaling and justified more studies to define the mechanisms, which are currently unknown.